ASGCT ✓

@ASGCTherapy · joined 11 Jan 2013

Advancing knowledge, awareness, and education leading to the discovery and clinical application of genetic and cellular therapies to alleviate human disease.

10 361Followers

2 002Following

8 708Posts total

1.9KViews on collected posts

Son gönderiler

ASGCT ✓@ASGCTherapy15 Sep

How do breakthrough cell and gene therapies actually reach patients? Sara Johnson Davis joins The Issue Podcast this month to discuss the growing role of patient advocacy in drug development, lessons from the sickle cell community, and the key barriers to access. Listen now ➡️

340 views · 4 likes · 0 reposts · 0 replies Open on X →

ASGCT ✓@ASGCTherapy14 Sep

It was a successful day of meaningful collaboration and conversation at today’s Policy Summit in Washington, D.C.! The day's engagement reinforced the importance of our field coming together to drive progress for patients and the broader healthcare community. Thank you to all h

446 views · 5 likes · 0 reposts · 0 replies Open on X →

ASGCT ✓@ASGCTherapy14 Sep

Submit an abstract to the Inaugural Canadian Gene and Cell Therapy Conference by October 1! Early-career investigators and trainees are invited to submit abstracts highlighting advances across the cell and gene therapy landscape from basic discovery through to clinical https://t

344 views · 3 likes · 1 reposts · 0 replies Open on X →

ASGCT ✓@ASGCTherapy9 Sep

ASGCT appreciates Congress acting through the bipartisan CR to pause OMB’s proposed Uniform Guidance changes. Thank you also to @RepLaLota, @RepGarbarino, and @RepDonBacon for speaking out for a fair, transparent federal funding process. ➡️ Read their letter here: https://t.co/

401 views · 2 likes · 0 reposts · 0 replies Open on X →

ASGCT ✓@ASGCTherapy9 Sep

📢 We're less than one week away from the 2026 Policy Summit! Join us for a full day of high-impact discussions across regulatory, manufacturing, access, and innovation in CGT. Can't make it in person? Attend virtually to get access to the same critical conversations from https:

363 views · 2 likes · 2 reposts · 0 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 5 gönderi, 10K–100K takipçi aralığıyla yan yana. boyutuna göre olağan erişim, çoğundan daha zayıf tepki.

Medyan görüntülenme363bu hesap99810K–100K için medyan

Erişim, %3.50%bu hesap3.68%10K–100K için medyan

Etkileşim, %1.12%bu hesap1.63%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	363	998	0.36×
Erişim (görüntülenme ÷ takipçi)	3.50%	3.68%	0.95×
Etkileşim oranı	1.12%	1.63%	0.69×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3639 Sep

401

34414 Sep

446

34015 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.10%9 Sep

0.50%

1.16%14 Sep

1.12%

1.18%15 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.63%.

What the audience does

Likes84.2%16 in total

Reposts15.8%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.